The Amersham connection
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.BILL CASTELL, 46, is chief executive of healthcare group Amersham International. He has worked for more than 20 years in the healthcare industry, and before joining Amersham was group commercial director of Wellcome.
Amersham has extensive contacts with the former Soviet Union. It is a founder member of the British Healthcare Consortium, a private sector initiative by some of the UK's biggest drug groups. BHC is involved in transferring Western healthcare technology and standards to the former Soviet Union.
Amersham has also established a joint venture with the Russian Atomic Energy Ministry for the production of isotopes with medical applications, part of the former Soviet Union's programme of converting military facilities to peaceful use. It has also linked up with the Institute of Cardiology in Moscow.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments